Diplomat’s Kelly Procailo Receives BCOP Certification
FLINT, Mich.– July 6, 2016 – The nation’s largest independent specialty pharmacy is proud to announce Kelly Procailo’s certification of BPS Board Certified Oncology Pharmacist.
Diplomat Pharmacy, Inc. (NYSE: DPLO) announced today that Kelly Procailo, PharmD, has received the Board of Pharmacy Specialties (BPS) Board Certified Oncology Pharmacist (BCOP) certification.
To learn more about Diplomat’s oncology program, click here.
BCOP certified pharmacists are increasingly recognized for their specialized training, knowledge, and skills in oncology practice. This is critical given the increasing number and complexity of drug therapies for oncology patients and the future drug pipeline. Procailo is one of about 1,900 oncology pharmacists in the nation who hold this certification.
Procailo is the clinical oncology manager within the Clinical Services Department at Diplomat. She maintains therapeutic and medication protocols/decision tools, drives policy and procedural development, and provides clinical support for all oncology initiatives.
“We are proud of Dr. Procailo’s accomplishment,” said Gary Rice, senior vice president of Clinical Services, Education and Human Resources at Diplomat. “She brings additional knowledge and experience to the Diplomat oncology team that will ultimately improve patient care initiatives and programs.”
Procailo began her career at the University of Michigan Health System (UMHS) as an infusion staff pharmacist. During her six-plus years at UMHS, she served with the anemia management program, the oral oncolytic program and the cancer center orders team, then served as the lead infusion pharmacist for the health system’s cancer center, overseeing operations.
Procailo serves on the University of Michigan College of Pharmacy Board of Governors and is a member of the Hematology and Oncology Pharmacists Association and the American Society of Clinical Oncology.
Diplomat (NYSE: DPLO) serves patients and physicians in all 50 states. Headquartered in Flint, Michigan, the company focuses on medication management programs for people with complex chronic diseases, including oncology, immunology, hepatitis, multiple sclerosis, specialized infusion therapy and many other serious or long-term conditions. Diplomat opened its doors in 1975 as a neighborhood pharmacy with one essential tenet: “Take good care of patients and the rest falls into place.” Today, that tradition continues—always focused on improving patient care and clinical adherence. For more information visit diplomat.is. Follow us on Twitter and LinkedIn and like us on Facebook.
Kali Lucas, Public Relations Coordinator
810.768.9580 | email@example.com
@DiplomatRx@JNJNews treatment Zytiga significantly cut the death risk for ... prostate cancer patients by 38% https://t.co/6Ga1okf4Ye @ASCO #ASCO174 days ago
@sloan_ketteringRT @sloan_kettering: Your immune system provides one of the best defenses against cancer. But sometimes it needs a little help. More about…2 weeks ago
@DiplomatRxThank you to @corpmagazine for recognizing Diplomat as a 2017 Michigan Economic Bright Spot awardee!2 weeks ago
@DiplomatRxFriend and Patient Advocate, Brenda Williams Hawkes was featured in @MyGoodDays Days this month!… https://t.co/TFGSoMecqO2 weeks ago
@DiplomatRxJeff Park Elected to Diplomat Board of Directors https://t.co/IMI1aRwNbm3 weeks ago